Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions

NCT: NCT07407738 · RECRUITING

NCT IDNCT07407738
StatusRECRUITING
Start Date2026-02-16
Completion2026-11-01
SponsorShunmei Medical (INDUSTRY)
First posted
Last updated

Brief Summary

Coronary artery disease is caused by narrowing of the artery lumen. Treatment with Percutaneous Coronary Intervention (PCI) may be needed. This is a minimally invasive procedure used to treat narrowed or blocked coronary arteries. Sometimes a stent is placed to keep the artery open. If the lesions in the coronary artery are calcified, this may cause difficulties for successful stent placement. The calcified plaques can be fractured via intravascular lithotripsy (IVL) with devices like ShockWave IVL and ShockFast IVL. The aim of this study is to compare the this relatively new ShockFast IVl with the more widely used ShockWave IVL.

Frequently Asked Questions

What is ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions?

ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions is a clinical trial registered under NCT07407738. Current status: RECRUITING.

What is the status of NCT07407738?

The current status of NCT07407738 (ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions) is: RECRUITING.

When did ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions start?

ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions started on 2026-02-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.